ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doull, I J M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doull, I J M
Archives of Disease in Childhood 2004;89:60-63
© 2004 BMJ Publishing Group & Royal College of Paediatrics and Child Health


REVIEW

The effect of asthma and its treatment on growth

I J M Doull

Correspondence to:
Correspondence to:
Dr I J M Doull
Cystic Fibrosis/Respiratory Unit, Department of Child Health, University Hospital of Wales, Cardiff CF14 4XW, UK; doullij{at}cf.ac.uk


ABSTRACT
Asthma has little, if any, significant effect on attained adult height. Untreated asthma results in a delay of puberty by approximately 1.3 years, and pubertal delay is likely to explain the majority of apparent growth failure in asthmatics. All currently available inhaled corticosteroids (ICS) result in growth suppression at conventional doses (400 µg/day of beclomethasone dipropionate equivalent), but the growth suppressive effects are relatively short lived, after which growth reverts to pretreatment levels. Younger, prepubertal children, appear more sensitive to the growth suppressive effects of ICS. Asthmatic children receiving conventional doses of ICS (400 µg/day of BDP equivalent) will attain an adult height indistinguishable from their predicted adult height (based on their mid parental height), and no different from non-asthmatics. Adult height could possibly be decreased in severe asthmatics, but this is unlikely to be greater than a 1.2 cm decrement. Recent longitudinal studies offer reassurance that at conventional doses ICS do not have significant long term effects on growth, and that their benefits consistently outweigh their side effects.


Abbreviations: BDP, beclomethasone dipropionate; BUD, budesonide; FP, fluticasone propionate; ICS, inhaled corticosteroids




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
L. Tata, R. Hubbard, T. McKeever, C. Smith, P Doyle, L Smeeth, J West, and S. Lewis
Fertility Rates in Women with Asthma, Eczema, and Hay Fever: A General Population-based Cohort Study
Am. J. Epidemiol., May 1, 2007; 165(9): 1023 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
A Lee
NHS Direct
Arch. Dis. Child., January 1, 2004; 89(1): 1 - 1.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health